At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Smoking Cessation Intervention for Yale Dining Employees
In Brief
A Phase 4 clinical trial evaluating Contingency management, Nicotine replacement therapy, and 2 other interventions for Smoking Cessation. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate a smoking cessation program for employees at the Yale University dining hall. Two pilot dining halls and six paired dining halls (3 test and 3 control sites) will be offered a contingency management/pharmacotherapy smoking cessation intervention at the work site.
Study Details
Timeline
Interventions
Participants in the intervention group will receive a tailored intervention that utilizes contingency management in which they receive monetary rewards for reducing or quitting smoking.
Participants have the option of using nicotine patch in combination with nicotine gum or lozenge
Individuals who do not respond initially to Nicotine Replacement Therapy will be offered varenicline as an alternative
Based on interest, participants can be referred to a telephone quitline or receive access to mobile text messaging programs or app based smoking cessation support